GS 101: Clinical Trials

1 trial of GS 101, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow GS 101: new trials by email Literature Review of GS 101 trials Research Report on GS 101

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1 Clinical Study Comparing GS101 and Dupixent® After Subcutaneous Injection
GS101 injection, U.S. commercial Dupixent®, CN commercial Dupixent® - Atopic Dermatitis (AD)
Phase 1CompletedJiangsu Genscend Biopharmaceutical Co., Ltd2942026-03-052026-10-15

Conditions studied

Dermatitis, Atopic (1)

Sponsors

Jiangsu Genscend Biopharmaceutical Co., Ltd (1)

Countries

China (1)